Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study

A recent experimental study suggested that proton pump inhibitors (PPI), widely used to prevent gastroduodenal complications of dual antiplatelet therapy, may increase the accumulation of the endogenous nitric oxide synthesis antagonist asymmetric dimethylarginine (ADMA), an adverse outcome predicto...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Mol Sci
Main Authors: Kruszelnicka, Olga, Świerszcz, Jolanta, Bednarek, Jacek, Chyrchel, Bernadeta, Surdacki, Andrzej, Nessler, Jadwiga
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4848910/
https://ncbi.nlm.nih.gov/pubmed/27092494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17040454
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki